Pancreatic Neoplasms

"Pancreatic Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA).

Descriptor ID	D010190
MeSH Number(s)	C04.588.274.761 C04.588.322.475 C06.301.761 C06.689.667 C19.344.421
Concept/Terms	Pancreatic Neoplasms Pancreatic Neoplasms Neoplasm, Pancreatic Pancreatic Neoplasm Pancreas Neoplasms Neoplasm, Pancreas Neoplasms, Pancreas Pancreas Neoplasm Neoplasms, Pancreatic Cancer of Pancreas Cancer of Pancreas Pancreas Cancers Pancreas Cancer Cancer, Pancreas Cancers, Pancreas Pancreatic Cancer Cancer, Pancreatic Cancers, Pancreatic Pancreatic Cancers Cancer of the Pancreas

Below are MeSH descriptors whose meaning is more general than "Pancreatic Neoplasms".

Diseases [C]
Neoplasms [C04]
Neoplasms by Site [C04.588]
Digestive System Neoplasms [C04.588.274]
Pancreatic Neoplasms [C04.588.274.761]
Endocrine Gland Neoplasms [C04.588.322]
Pancreatic Neoplasms [C04.588.322.475]
Digestive System Diseases [C06]
Digestive System Neoplasms [C06.301]
Pancreatic Neoplasms [C06.301.761]
Pancreatic Diseases [C06.689]
Pancreatic Neoplasms [C06.689.667]
Endocrine System Diseases [C19]
Endocrine Gland Neoplasms [C19.344]
Pancreatic Neoplasms [C19.344.421]

Below are MeSH descriptors whose meaning is more specific than "Pancreatic Neoplasms".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Pancreatic Neoplasms" by people in this website by year, and whether "Pancreatic Neoplasms" was a major or minor topic of these publications.

Bar chart showing 272 publications over 29 distinct years, with a maximum of 24 publications in 2017

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	3	0	3
1997	5	0	5
1999	3	2	5
2000	6	0	6
2001	3	0	3
2002	0	1	1
2003	5	1	6
2004	6	1	7
2005	3	1	4
2006	3	1	4
2007	8	0	8
2008	5	1	6
2009	9	1	10
2010	17	1	18
2011	5	0	5
2012	12	2	14
2013	11	2	13
2014	14	0	14
2015	16	1	17
2016	15	0	15
2017	22	2	24
2018	10	1	11
2019	15	0	15
2020	11	4	15
2021	8	0	8
2022	7	0	7
2023	12	0	12
2024	8	3	11
2025	5	0	5

Below are the most recent publications written about "Pancreatic Neoplasms" by people in Profiles.

Peura J, Johnson C, Pitarresi JR. To EMT or Not to EMT: Ablation of Mesenchymal Tumor Cell Lineages Reveals the Essential Role of EMT in Pancreatic Cancer Initiation and Evolution. Cancer Res. 2025 Jun 16; 85(12):2146-2148.

View in: PubMed
Widdowson KR, Chung S, Yang M, Lindberg JM. Hepatoid carcinoma of the pancreas in a patient with familial adenomatous polyposis. BMJ Case Rep. 2025 Jun 12; 18(6).

View in: PubMed
Weissenrieder JS, Peura J, Paudel U, Bhalerao N, Weinmann N, Johnson C, Wengyn M, Drager R, Furth EE, Simin K, Ruscetti M, Stanger BZ, Rustgi AK, Pitarresi JR, Foskett JK. Mitochondrial Ca2+ controls pancreatic cancer growth and metastasis by regulating epithelial cell plasticity. Cell Rep. 2025 May 27; 44(5):115627.

View in: PubMed
Ahmed KS, Issaka SM, Marcinak CT, Virani SS, Jaraczewski T, Afshar M, Mayampurath A, Churpek MM, Mathew J, Zafar SN. Machine Learning-Driven Modeling to Predict Postdischarge Venous Thromboembolism After Pancreatectomy for Pancreas Cancer. Ann Surg Oncol. 2025 Jun; 32(6):4085-4093.

View in: PubMed
Nisco A, Sposato A, Ardone M, Leone P, Cardone RA, Console L, Indiveri C, Zanier K, Barile M. Supplying LSD1 with FAD in pancreatic cancer: A matter of protein-protein interaction? Arch Biochem Biophys. 2025 Feb; 764:110291.

View in: PubMed
Machicado JD, Sheth SG, Chalhoub JM, Forbes N, Desai M, Ngamruengphong S, Papachristou GI, Sahai V, Nassour I, Abidi W, Alipour O, Amateau SK, Coelho-Prabhu N, Cosgrove N, Elhanafi SE, Fujii-Lau LL, Kohli DR, Marya NB, Pawa S, Ruan W, Thiruvengadam NR, Thosani NC, Qumseya BJ. American Society for Gastrointestinal Endoscopy guideline on the role of endoscopy in the diagnosis and management of solid pancreatic masses: summary and recommendations. Gastrointest Endosc. 2024 Nov; 100(5):786-796.

View in: PubMed
Delgado-Coka LA, Roa-Pe?a L, Babu S, Horowitz M, Petricoin EF, Matrisian LM, Blais EM, Marchenko N, Allard FD, Akalin A, Jiang W, Larson BK, Hendifar AE, Picozzi VJ, Choi M, Shroyer KR, Escobar-Hoyos LF. Keratin 17 is a prognostic and predictive biomarker in pancreatic ductal adenocarcinoma. Am J Clin Pathol. 2024 Sep 03; 162(3):314-326.

View in: PubMed
Chibaya L, DeMarco KD, Lusi CF, Kane GI, Brassil ML, Parikh CN, Murphy KC, Chowdhury SR, Li J, Ma B, Naylor TE, Cerrutti J, Mori H, Diaz-Infante M, Peura J, Pitarresi JR, Zhu LJ, Fitzgerald KA, Atukorale PU, Ruscetti M. Nanoparticle delivery of innate immune agonists combined with senescence-inducing agents promotes T cell control of pancreatic cancer. Sci Transl Med. 2024 08 28; 16(762):eadj9366.

View in: PubMed
Chowdhury SR, Murphy KC, Parikh CN, DeMarco KD, Zhou L, Ruscetti M. Measuring the impact of therapy-induced senescence on NK cell phenotypes in cancer. Methods Cell Biol. 2024; 190:171-201.

View in: PubMed
Li AL, Sugiura K, Nishiwaki N, Suzuki K, Sadeghian D, Zhao J, Maitra A, Falvo D, Chandwani R, Pitarresi JR, Sims PA, Rustgi AK. FRA1 controls acinar cell plasticity during murine KrasG12D-induced pancreatic acinar to ductal metaplasia. Dev Cell. 2024 11 18; 59(22):3025-3042.e7.

View in: PubMed

People

Explore

Similar Concepts

Top Journals